The impact of histologic tumor response on survival of patients treated with neoadjuvant mFOLFOX6 plus bevacizumab for the synchronous liver metastases from colorectal cancer.
Yu Katayose
No relevant relationships to disclose
Kazuyuki Ishida
No relevant relationships to disclose
Kei Nakagawa
No relevant relationships to disclose
Junichiro Yamauchi
No relevant relationships to disclose
Masaya Oikawa
No relevant relationships to disclose
Naoki Sakurai
No relevant relationships to disclose
Hiroaki Musha
No relevant relationships to disclose
Hiromune Shimamura
No relevant relationships to disclose
Koh Miura
No relevant relationships to disclose
Fuyuhiko Motoi
No relevant relationships to disclose
Shinichi Egawa
No relevant relationships to disclose
Michiaki Unno
No relevant relationships to disclose